[go: up one dir, main page]

WO2003061579A3 - Compositions pharmaceutiques a base de phtalocyanine et de porphyrazine - Google Patents

Compositions pharmaceutiques a base de phtalocyanine et de porphyrazine Download PDF

Info

Publication number
WO2003061579A3
WO2003061579A3 PCT/US2003/001619 US0301619W WO03061579A3 WO 2003061579 A3 WO2003061579 A3 WO 2003061579A3 US 0301619 W US0301619 W US 0301619W WO 03061579 A3 WO03061579 A3 WO 03061579A3
Authority
WO
WIPO (PCT)
Prior art keywords
pharmaceutical compositions
administration
phthalocyanine
porphyrazine
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2003/001619
Other languages
English (en)
Other versions
WO2003061579A2 (fr
Inventor
Richard W Compans
Luigi G Marzilli
Dabney W Dixon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Emory University
Georgia State University Research Foundation Inc
Original Assignee
Emory University
Georgia State University Research Foundation Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Emory University, Georgia State University Research Foundation Inc filed Critical Emory University
Priority to AU2003205227A priority Critical patent/AU2003205227A1/en
Publication of WO2003061579A2 publication Critical patent/WO2003061579A2/fr
Publication of WO2003061579A3 publication Critical patent/WO2003061579A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/409—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having four such rings, e.g. porphine derivatives, bilirubin, biliverdine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

L'invention concerne des compositions pharmaceutiques contenant un composé neutre ou chargé négativement présentant une structure phtalocyanine ou l'une des porphyrazines ou le complexe métallique dérivant de ce composé. Ces compositions sont efficaces pour atténuer une infection par le VIH et d'autres agents pathogènes induisant des maladies sexuellement transmissibles. Lesdites compositions peuvent être adaptées à n'importe quel mode d'administration. De préférence, la composition est adaptée à une administration topique, et notamment à une administration mucosale, la composition préférée étant adaptée à une administration par voie vaginale ou rectale.
PCT/US2003/001619 2002-01-18 2003-01-17 Compositions pharmaceutiques a base de phtalocyanine et de porphyrazine Ceased WO2003061579A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2003205227A AU2003205227A1 (en) 2002-01-18 2003-01-17 Phthalocyanine and porphyrazine pharmaceutical compositions

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US34994402P 2002-01-18 2002-01-18
US60/349,944 2002-01-18

Publications (2)

Publication Number Publication Date
WO2003061579A2 WO2003061579A2 (fr) 2003-07-31
WO2003061579A3 true WO2003061579A3 (fr) 2003-12-04

Family

ID=27613344

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2003/001619 Ceased WO2003061579A2 (fr) 2002-01-18 2003-01-17 Compositions pharmaceutiques a base de phtalocyanine et de porphyrazine

Country Status (2)

Country Link
AU (1) AU2003205227A1 (fr)
WO (1) WO2003061579A2 (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2426978A (en) * 2005-06-08 2006-12-13 Yen Cheng Tsai Novel Phthalocyanine Derivatives, Synthetic Process thereof and their application in optical recording media
GB0519169D0 (en) 2005-09-21 2005-10-26 Leuven K U Res & Dev Novel anti-viral strategy
US20070264296A1 (en) 2006-05-10 2007-11-15 Myntti Matthew F Biofilm extracellular polysachharide solvating system
US7959943B2 (en) 2006-05-10 2011-06-14 Medtronics Xomed, Inc. Solvating system and sealant for medical use in the middle or inner ear
US7976873B2 (en) * 2006-05-10 2011-07-12 Medtronic Xomed, Inc. Extracellular polysaccharide solvating system for treatment of bacterial ear conditions
US7993675B2 (en) 2006-05-10 2011-08-09 Medtronic Xomed, Inc. Solvating system and sealant for medical use in the sinuses and nasal passages
US8088095B2 (en) 2007-02-08 2012-01-03 Medtronic Xomed, Inc. Polymeric sealant for medical use
US20100221307A1 (en) * 2008-02-20 2010-09-02 Daiwabo Holdings Co., Ltd. Antiviral agents, antiviral fibers and antiviral fiber structures
EP2303254B1 (fr) 2008-06-12 2019-10-30 Medtronic Xomed, Inc. Produit pour le traitement de plaies chroniques avec un système extracellulaire de solvant comprenant une substance polymérique
US20100086576A1 (en) 2008-10-06 2010-04-08 Myntti Matthew F Antimicrobial composition and methods of making and using same
US8580294B2 (en) 2010-10-19 2013-11-12 International Partnership For Microbicides Platinum-catalyzed intravaginal rings
JP6463629B2 (ja) 2011-05-10 2019-02-06 ネクスト サイエンス アイピー ホールディングス ピーティワイ エルティーディ 抗菌性固体およびその製造方法
CA2909383C (fr) 2012-04-12 2020-11-10 University Of Saskatchewan Composes phtalocyanine utiles en tant qu'inhibiteurs reca et procedes d'utilisation associes
US10137031B2 (en) 2013-11-14 2018-11-27 International Partnership For Microbicides, Inc. Combination therapy intravaginal rings
US10537658B2 (en) 2017-03-28 2020-01-21 DePuy Synthes Products, Inc. Orthopedic implant having a crystalline gallium-containing hydroxyapatite coating and methods for making the same
US10537661B2 (en) 2017-03-28 2020-01-21 DePuy Synthes Products, Inc. Orthopedic implant having a crystalline calcium phosphate coating and methods for making the same
CN117715987A (zh) * 2021-08-26 2024-03-15 Dic株式会社 具有抗菌作用或抗病毒作用的酞菁颜料

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992017182A1 (fr) * 1991-04-03 1992-10-15 Agouron Pharmaceuticals, Inc. Procedes et composes d'inhibition de l'activite de rnase h de la transcriptase inverse
US5281616A (en) * 1988-05-23 1994-01-25 Georgia State University Foundation, Inc. Porphyrin and phthalocyanine antiviral compositions
US6068851A (en) * 1996-05-09 2000-05-30 Infectio Recherche, Inc. Formulation for use in the prevention of pathogen induced diseases including HIV and HSV

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5281616A (en) * 1988-05-23 1994-01-25 Georgia State University Foundation, Inc. Porphyrin and phthalocyanine antiviral compositions
WO1992017182A1 (fr) * 1991-04-03 1992-10-15 Agouron Pharmaceuticals, Inc. Procedes et composes d'inhibition de l'activite de rnase h de la transcriptase inverse
US6068851A (en) * 1996-05-09 2000-05-30 Infectio Recherche, Inc. Formulation for use in the prevention of pathogen induced diseases including HIV and HSV

Also Published As

Publication number Publication date
WO2003061579A2 (fr) 2003-07-31
AU2003205227A1 (en) 2003-09-02

Similar Documents

Publication Publication Date Title
WO2003061579A3 (fr) Compositions pharmaceutiques a base de phtalocyanine et de porphyrazine
WO2002004422A3 (fr) Carboxamides heterocycliques comme agents antiviraux
WO2005063744A3 (fr) Composes d'imidazo[4,5-c]pyridine et methodes de traitement antiviral
WO2002088124A3 (fr) Composes therapeutiques
HK1038744A1 (zh) 用於治療炎性疾病的化合物
BR0111206A (pt) Derivados de arilmetilamina para uso como inibidores de triptase
EP1340755A4 (fr) Agents de traitement des infections a helicobacter
HRP20180330T1 (hr) Pripravci za povećavanje aktivnosti telomeraze i liječenje infekcije hiv-om
WO1998056761A3 (fr) Derives de benzimidazole
CA2415068A1 (fr) Renforcement global de l'organisme
WO2003053368A3 (fr) Derives de chalcone et leur utilisation dans le traitement de maladies
WO2003006425A3 (fr) Nouveaux composes convenant comme anti-inflammatoires, immuno-modulateurs et anti-proliferants
CA2413163A1 (fr) 3'-promedicaments de 2'-desoxy-.beta.-l-nucleosides
GB0321003D0 (en) Compounds, compositions and uses
WO2005040171A8 (fr) Derives de pyrazolo-pyrimidine et d'imidazo-pyrimidine
EP1127572A3 (fr) Utilisation de flavones dans le traitement de maladies induites par cyclooxygenase-2
BG103969A (en) C-4"-substituted macrolide derivatives
WO2001087882A3 (fr) Derives de pyrrolopyridinone substitues utiles en tant qu'inhibiteurs de la phosphodiesterase
WO2002002096A3 (fr) Renforcement global de l'organisme
CA2312840A1 (fr) Utilisation de polyols pour lutter contre les infections aux levures et preparations de polyols utilisees a cet effet
WO2002094179A3 (fr) Nouvelles compositions microbicides topiques
WO2000040583A3 (fr) Derives d'imidazo[4,5-c]pyridine-4-one
WO2002094796A3 (fr) Derives de la benzo[g]quinoxaline composes efficaces contre les maladies infectieuses
AU2003205717A1 (en) New medicinal compositions containing heterocyclical compounds in addition to anticholinergics
WO2005023792A3 (fr) Composes macrocycliques utiles en tant qu'agents parmaceutiques

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SC SD SE SG SK SL TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LU MC NL PT SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP